Option chain shows key data for Instil Bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Instil Bio.

Instil Bio (NASDAQ:TIL) Stock, Option Chain

Instil Bio

Overview

News

Earnings

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Comments

Instil Bio Option Chain

No option chain data available. Please try again later